Cargando…
Argatroban Resistance and Successful Adjunctive Anticoagulation for Cerebral Venous Sinus Thrombosis With SERPINC1 Mutation: A Case Report
OBJECTIVES: Anticoagulation therapy for cerebral venous sinus thrombosis (CVST) with antithrombin (AT) deficiency due to SERPINC1 mutation does not often yield the expected outcomes. Argatroban may be effective for thrombophilia caused by SERPINC1 mutation. However, argatroban resistance deserves at...
Autores principales: | Ma, Hongrui, Zhang, Qihan, Gu, Yaqin, Ji, Xunming, Duan, Jiangang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101707/ https://www.ncbi.nlm.nih.gov/pubmed/37064580 http://dx.doi.org/10.1212/CPJ.0000000000200122 |
Ejemplares similares
-
Predictors of successful endovascular treatment in severe cerebral venous sinus thrombosis
por: Yang, Xiaoxu, et al.
Publicado: (2019) -
Anticoagulation delay does not affect the functional outcome of cerebral venous thrombosis
por: Ji, Kangxiang, et al.
Publicado: (2020) -
An Exploration of Anti-Inflammatory Therapy in Acute/Subacute Severe Cerebral Venous Thrombosis with Hereditary Protein C/S Deficiency: Case Series
por: Hao, Wensi, et al.
Publicado: (2023) -
Cerebral venous sinus thrombosis in homocystinuria: Dietary intervention in conjunction with anticoagulation
por: Yap, Sufin, et al.
Publicado: (2017) -
Successful endovascular mechanical thrombectomy in anticoagulation-resistant COVID-19 associated cerebral venous sinus thrombosis
por: Sajjad, Ali, et al.
Publicado: (2021)